AZATHIOPRINE SODIUM

Post-LOE

azathioprine sodium

Hikma

ANDAINJECTIONINJECTABLE

Approved

Mar 1995

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

AZATHIOPRINE SODIUM (azathioprine sodium) by Hikma is clinical pharmacology azathioprine is well absorbed following oral administration. Approved for active rheumatoid arthritis to reduce signs, symptoms, active rheumatoid arthritis (ra) to reduce signs and 2 more indications. First approved in 1995.

Drug data last refreshed 18h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Azathioprine is well absorbed following oral administration. Maximum serum radioactivity occurs at 1 to 2 hours after oral S-azathioprine and decays with a half-life of 5 hours. This is not an estimate of the half-life of azathioprine itself, but is the decay rate for all…

Worked on AZATHIOPRINE SODIUM at Hikma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

AZATHIOPRINE SODIUM

Mechanism of Action

Indications (4)